Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.

Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW; Lynch Syndrome prediction model validation study group..

J Natl Cancer Inst. 2015 Nov 18;108(2). pii: djv308. doi: 10.1093/jnci/djv308.

PMID:
26582061
2.

External Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain.

van Hoeven L, Vergouwe Y, de Buck PD, Luime JJ, Hazes JM, Weel AE.

PLoS One. 2015 Jul 22;10(7):e0131963. doi: 10.1371/journal.pone.0131963.

3.

Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.

Judkins T, Leclair B, Bowles K, Gutin N, Trost J, McCulloch J, Bhatnagar S, Murray A, Craft J, Wardell B, Bastian M, Mitchell J, Chen J, Tran T, Williams D, Potter J, Jammulapati S, Perry M, Morris B, Roa B, Timms K.

BMC Cancer. 2015 Apr 2;15:215. doi: 10.1186/s12885-015-1224-y.

4.

Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.

Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ.

Cancer Genet. 2014 Oct-Dec;207(10-12):495-502. doi: 10.1016/j.cancergen.2014.10.002.

5.

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S; Gliogene Consortium., Bondy ML, Melin BS.

Neuro Oncol. 2014 Oct;16(10):1333-40. doi: 10.1093/neuonc/nou052.

6.

Identification of patients at risk for hereditary colorectal cancer.

Mishra N, Hall J.

Clin Colon Rectal Surg. 2012 Jun;25(2):67-82. doi: 10.1055/s-0032-1313777.

7.

Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes.

Roy S, Majumdar AP.

J Stem Cell Res Ther. 2012 Dec 17;Suppl 7(6). pii: 10342.

8.

Prediction models in Lynch syndrome.

Kastrinos F, Balmaña J, Syngal S.

Fam Cancer. 2013 Jun;12(2):217-28. doi: 10.1007/s10689-013-9632-0. Review.

9.

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.

Wang Y, Wang Y, Li J, Cragun J, Hatch K, Chambers SK, Zheng W.

J Hematol Oncol. 2013 Mar 25;6:22. doi: 10.1186/1756-8722-6-22.

10.

Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Li D, Hu F, Wang F, Cui B, Dong X, Zhang W, Lin C, Li X, Wang D, Zhao Y.

PLoS One. 2013;8(3):e51240. doi: 10.1371/journal.pone.0051240.

11.

Identification of Lynch syndrome among patients with colorectal cancer.

Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A; EPICOLON Consortium..

JAMA. 2012 Oct 17;308(15):1555-65. doi: 10.1001/jama.2012.13088.

12.

Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.

Grover S, Kastrinos F, Steyerberg EW, Cook EF, Dewanwala A, Burbidge LA, Wenstrup RJ, Syngal S.

JAMA. 2012 Aug 1;308(5):485-92. doi: 10.1001/jama.2012.8780.

13.

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

Mercado RC, Hampel H, Kastrinos F, Steyerberg E, Balmana J, Stoffel E, Cohn DE, Backes FJ, Hopper JL, Jenkins MA, Lindor NM, Casey G, Haile R, Madhavan S, de la Chapelle A, Syngal S; Colon Cancer Family Registry..

Genet Med. 2012 Jul;14(7):670-80. doi: 10.1038/gim.2012.18.

14.

Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.

Kastrinos F, Steyerberg EW, Balmaña J, Mercado R, Gallinger S, Haile R, Casey G, Hopper JL, LeMarchand L, Lindor NM, Newcomb PA, Thibodeau SN, Syngal S; Colon Cancer Family Registry..

Gut. 2013 Feb;62(2):272-9. doi: 10.1136/gutjnl-2011-301265.

15.

Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries.

Monteiro Santos EM, Valentin MD, Carneiro F, de Oliveira LP, de Oliveira Ferreira F, Junior SA, Nakagawa WT, Gomy I, de Faria Ferraz VE, da Silva Junior WA, Carraro DM, Rossi BM.

BMC Cancer. 2012 Feb 9;12:64. doi: 10.1186/1471-2407-12-64.

16.

Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.

Bartley AN, Luthra R, Saraiya DS, Urbauer DL, Broaddus RR.

Cancer Prev Res (Phila). 2012 Feb;5(2):320-7. doi: 10.1158/1940-6207.CAPR-11-0288.

17.

High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.

Mukherjee B, Rennert G, Ahn J, Dishon S, Lejbkowicz F, Rennert HS, Shiovitz S, Moreno V, Gruber SB.

Gastroenterology. 2011 Jun;140(7):1919-26. doi: 10.1053/j.gastro.2011.02.071.

18.

Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer.

Sinicrope FA, Yang ZJ.

Future Oncol. 2011 Mar;7(3):467-74. doi: 10.2217/fon.11.5.

19.

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Dinh TA, Rosner BI, Atwood JC, Boland CR, Syngal S, Vasen HF, Gruber SB, Burt RW.

Cancer Prev Res (Phila). 2011 Jan;4(1):9-22. doi: 10.1158/1940-6207.CAPR-10-0262.

20.

Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.

Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, Casey G, Woods MO, Thibodeau SN, Lindor NM.

Clin Gastroenterol Hepatol. 2011 Jun;9(6):497-502. doi: 10.1016/j.cgh.2010.10.021.

Items per page

Supplemental Content

Support Center